PRESS RELEASE GKNM Hospital Robotic Onco Surgery Conference (ROSCON 2026)
Advancing the Frontiers of Robotic Oncosurgery in India Coimbatore, March 21, 2026 — The prestigious ROSCON 2026 (Robotic Oncosurgery Conference) has commenced at G.Kuppuswamy Naidu Memorial Hospital (GKNM Hospital), Coimbatore, bringing together leading national and international experts in the field of robotic cancer surgery. Scheduled from March 20th to 22nd, 2026, the conference serves as a dynamic platform for knowledge exchange, skill enhancement, and the advancement of cutting-edge oncological care.
The event was inaugurated by Dr. Ragupathy Veluswamy, Chief Executive Officer of GKNM Hospital.The Guest of Honour for the occasion was Dr. Somasekhar S P, Chairman, Medical Advisory Board (MAB),Aster DM Healthcare GCC and India. The conference was further graced by Dr. Subbiah Shanmugam,President of the Tamil Nadu Association of Surgical Oncology (TASO).Prominent GKNM Hospital oncology consultants who participated in the event included Dr. Sivanesan,Chairman – Department of Oncology; Dr. Arul Raj, Consultant Oncologist, Robotic and HIPEC Surgeon; Dr.Praveen Ravishankaran, Consultant Laparoscopic, Robotic and HIPEC Surgeon; and Dr. Mohanraj, Chief Surgical Oncologist.
Dr. Praveen Ravishankaran, Dr. Sivanesan, Dr. Subbiah Shanmugam, Dr.Somasekhar S P, Dr. Ragupathy Veluswamy, Dr. Arul Raj and Dr. Mohanraj ROSCON 2026 has been thoughtfully curated to showcase the latest innovations and evolving techniques in robotic-assisted cancer surgery. With a strong emphasis on precision, minimally invasive approaches, and improved patient outcomes, the conference highlights the transformative impact of robotics in modern oncological practice.A major highlight of the conference is the live surgical workshops, where complex oncological procedures—including robotic esophagectomy and advanced thoracic and gastrointestinal surgeries—are being demonstrated in real time by expert surgeons. These sessions provide invaluable insights into surgical planning, intraoperative strategies, and postoperative care,enabling delegates to directly observe and learn from leaders in the field.The conference also features hands-on training sessions, particularly tailored for gynecologists and surgeons seeking practical exposure to robotic platforms such as the Da Vinci Xi system. These sessions offer participants a unique opportunity to experience the precision, dexterity, and ergonomic advantages of robotic-assisted surgery under expert supervision.In addition to the scientific program, ROSCON 2026 fosters academic collaboration through panel discussions, keynote lectures, and interactive sessions spanning a wide range of oncological specialties—including thoracic, gastrointestinal, gynecological, and urological malignancies.The event has attracted a diverse group of delegates, including surgeons, oncologists, trainees, and healthcare professionals from across the country.Speaking on the occasion, the organizing committee emphasized that ROSCON aims not only to disseminate advanced surgical knowledge but also to build a strong community of robotic surgeons committed to improving access to high-quality cancer care across India.The enthusiastic participation and academic rigor witnessed at ROSCON 2026 reflect the rapidly growing adoption of robotic surgery in oncology and its potential to redefine standards of care. The conference is expected to catalyze future collaborations, training initiatives, and innovations in minimallyinvasive cancer treatment.About ROSCONROSCON (Robotic Oncosurgery Conference) is a premier academic initiative dedicated to advancing robotic-assisted surgical techniques in oncology. It aims to bridge the gap between technology and clinical practice by providing a robust platform for education, innovation, and collaboration among surgeons and healthcare professionals.